Pilocarpine After Combined Cataract/Trabectome Surgery
Status:
Terminated
Trial end date:
2021-01-21
Target enrollment:
Participant gender:
Summary
Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular
pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression
of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess
whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other
words cause the pupil to constrict or become smaller) provides additional benefit to the
success of Trabectome and cataract surgery.